C2C: COMBINE-2 for Cabotegravir+Rilpivirine LA Regimen - A Prospective Cohort Study to Monitor Effectiveness, Adherence and Resistance (215160)First published 26/08/2021 Last updated 05/06/2024 EU PAS number: EUPAS42609StudyOngoing